The Cooper Companies, Inc. (NASDAQ:COO) Receives $117.00 Average PT from Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has been given an average rating of “Moderate Buy” by the twelve research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $117.00.

A number of analysts recently issued reports on COO shares. Morgan Stanley decreased their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Wells Fargo & Company raised their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th.

Cooper Companies Stock Up 1.8 %

Shares of NASDAQ COO opened at $90.68 on Thursday. Cooper Companies has a 12-month low of $84.76 and a 12-month high of $112.38. The firm has a market cap of $18.10 billion, a PE ratio of 46.50, a P/E/G ratio of 2.40 and a beta of 0.99. The company’s fifty day simple moving average is $97.24 and its 200 day simple moving average is $98.95. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.87 EPS. As a group, sell-side analysts forecast that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors have recently bought and sold shares of the business. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies in the third quarter worth $25,000. Covestor Ltd lifted its stake in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. boosted its holdings in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the last quarter. West Financial Advisors LLC purchased a new position in shares of Cooper Companies during the fourth quarter valued at about $49,000. Finally, Friedenthal Financial bought a new stake in shares of Cooper Companies in the third quarter worth about $50,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.